Teosona

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Teosona

What is Teosona?

Teosona is a pharmaceutical formulation containing the active ingredient betamethasone dipropionate. It belongs to a class of medications known as topical corticosteroids. These medications are applied directly to the skin to manage various dermatological conditions characterized by inflammation and itching.

Therapeutic Class and Function

As a corticosteroid, the active component in Teosona works by mimicking the effects of hormones naturally produced by the adrenal glands. When applied to the skin, it helps to reduce the swelling, redness, and irritation associated with immune system responses in the localized area.

Common Uses

Teosona is typically utilized for the management of inflammatory skin disorders that respond to steroid treatment. These conditions may include:

  • Eczema and Dermatitis: Various forms of skin inflammation that result in dry, itchy, or swollen patches.
  • Psoriasis: A chronic condition where skin cells build up rapidly, forming scales and itchy, dry patches (excluding widespread plaque psoriasis).
  • Lichen Planus: An inflammatory condition that can affect the skin and mucous membranes.
  • Contact Sensitivity: Skin reactions caused by allergens or irritants.

Composition and Formulations

The medication is designed for external use only and is available in different topical forms, such as creams or ointments, to suit different skin types and the nature of the skin concern being addressed. The choice of formulation often depends on whether the affected area is dry, oily, or weeping.

What side effects are possible with Teosona?

Adverse Reactions and Safety Profile

Teosona (Theophylline) has a narrow therapeutic window, meaning there is a small difference between the effective dose and a dose that may cause serious toxicity. Side effects are often dose-related and become more pronounced as serum concentrations exceed the upper limit of the target range (typically 10–20 mg/L). Monitoring of serum levels is a critical safety measure.

Adverse Reaction Categories

Common adverse reactions, often seen even within the therapeutic range, primarily affect the Gastrointestinal and Nervous Systems. These include: nausea, vomiting, diarrhea, headache, insomnia (trouble sleeping), tremors, and feeling restless or irritable.

Serious Adverse Reactions

Serious and life-threatening reactions are associated with higher serum concentrations (toxicity/overdose) and involve the Cardiac and Central Nervous Systems. These include:

  • Seizures (which may lead to permanent brain damage or death).
  • Serious Cardiac Arrhythmias (irregular heartbeats), including ventricular tachycardia or cardiac arrest.
  • Persistent or severe vomiting, which can be an early sign of toxicity.

Population-Specific and Dose-Related Safety

Risk of severe toxicity is increased in certain populations due to slower drug clearance from the body, necessitating careful dosage adjustment and monitoring:

  • Older Adults (over 60 years of age).
  • Infants (especially those under one year old).
  • Patients with Heart Failure or Liver Disease.
  • Patients with acute fever (102 F or higher for 24 hours or more).

The drug is contraindicated in patients with known hypersensitivity to xanthine derivatives, and its use requires caution in individuals with pre-existing conditions such as active peptic ulcer disease, cardiac arrhythmias, or a seizure disorder, as the drug may exacerbate these conditions.

Overdose and Emergency Response

The officially documented overdose profile of Teosona (Choline Theophyllinate) focuses on the potential for severe and potentially fatal toxicity due to the drug’s narrow therapeutic index. The key physiological systems affected are the Central Nervous System and the Cardiovascular System. Manifestations of toxicity may include severe or persistent vomiting, ongoing headache, continuing restlessness, and tremors. More critically, overdose can present with life-threatening events such as convulsions (seizures), ventricular arrhythmias, or peripheral vascular collapse, which regulatory sources state may occur suddenly without preceding milder symptoms.

Toxicity is often correlated with serum concentrations exceeding 20 micrograms/mL. Regulatory documents stipulate that immediate medical attention must be sought upon the presentation of any suspected sign or symptom of toxicity. Measuring the serum theophylline concentration is required in such cases, as this procedure is cited as the most reliable method for predicting potentially life-threatening outcomes. Management protocols require symptomatic and supportive treatment. Certain populations have a documented increased risk for toxicity, including children, the elderly, and individuals with concurrent conditions such as liver disease, uncorrected acidemia, or severe infection.

Therapeutic Uses of Teosona

What Teosona Treats: Main Uses and Benefits

Teosona is used in situations involving certain distressing symptoms related to physical discomfort in the airways. It is commonly used across conditions presenting with episodic or fluctuating manifestations, such as those associated with chronic asthma or other conditions where symptoms may intensify temporarily. This medication is applied across domains where additional symptomatic support is needed, relevant for managing symptoms that interfere with daily comfort, such as shortness of breath and wheezing, and in specialized contexts, for addressing irregular breathing patterns in premature infants.

The general benefit is providing support that helps ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms. It assists with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.

“This medication is considered relevant in contexts involving heightened physiological stress, supporting patients during episodes of heightened discomfort.”

Quick Fact: Relevant for Easing Symptoms of Breathing Difficulties and Airway Tightness

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

Official Eligibility and Restriction Profile

The eligibility profile for Teosona (Choline Theophyllinate/Oxtriphylline) is strictly governed by regulatory criteria, defining populations who are prohibited from use and those who require conditional monitoring.

Category Regulatory Status & Population Restriction
Absolute Contraindication Patients with known hypersensitivity to any xanthine derivative, or with active peptic ulcer disease [Source 2.4, 4.4]. Use is also prohibited in patients with untreated seizure disorders [Source 4.5].
Age-Related Eligibility Infants under one year of age are at a significantly increased risk of toxicity due to highly variable and slow clearance [Source 3.2, 4.2]. Older adults (typically ge 60 years) require caution due to reduced drug clearance [Source 1.5].
Conditional Use Patients with hepatic impairment (e.g., cirrhosis), acute pulmonary edema, congestive heart failure, or severe fever have documented reduced drug clearance. Use in these groups is restricted and requires careful monitoring [Source 1.3, 4.2].
Pregnancy/Lactation The medicine is classified as Pregnancy Category C (FDA). Use is conditional and should occur only if the potential benefit justifies the risk [Source 3.1]. Theophylline is secreted into human milk [Source 2.4].

Connection to the overall eligibility profile: Official regulatory documents define eligibility by establishing absolute contraindications and identifying populations where altered metabolic clearance significantly elevates the risk of severe toxicity. These formal restrictions, which include specific age groups and comorbidities, mandate that use is either prohibited or conditional based on the risk documented in the official label.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Teosona (Choline Theophyllinate) interacts primarily through pharmacokinetic mechanisms by affecting its clearance, which is mediated by the liver enzyme CYP1A2. The official interaction profile is defined by substances that modulate this enzyme's activity and substances that cause additive pharmacological effects.


Documented Exposure-Altering Interactions

Interactions involving CYP1A2 modulation significantly alter the plasma concentration of Teosona, as documented in regulatory sources.

Interaction Type Examples of Interacting Substances Official Outcome of Interaction
Reduced Clearance (Increased Exposure) Ciprofloxacin, Cimetidine, Fluvoxamine Significantly increases plasma concentration of Teosona.
Increased Clearance (Reduced Exposure) Rifampin, Phenytoin, Carbamazepine, Tobacco Smoking, St. John's Wort Significantly reduces plasma concentration of Teosona.

Pharmacodynamic and Substance Interactions

  • Additive Effects: Co-administration with other xanthine derivatives, such as caffeine, or Beta-Adrenergic Agonists may result in an additive pharmacodynamic effect.
  • Antagonism: Theophylline is documented to act as an adenosine receptor antagonist, which may diminish the pharmacological effect of co-administered Adenosine.
  • Alcohol: Consumption of a large single dose of alcohol is documented in regulatory sources to decrease Teosona clearance, potentially increasing exposure.

Population-Specific Interaction Notes

Interaction-related risk is officially noted as heightened in specific patient populations. The clinical significance of drug interactions is greater in individuals with hepatic impairment (e.g., liver disease) due to Teosona’s reliance on the liver for metabolism.

Mechanism of Action

Mechanism of Action

The active component of Teosona, Theophylline, exerts its effects through multiple, converging pharmacodynamic mechanisms. The primary mechanism is the non-selective inhibition of Phosphodiesterase (PDE) enzymes, chiefly the PDE3 and PDE4 isoforms, which are abundant in airway smooth muscle. This action raises intracellular levels of the secondary messenger cyclic Adenosine Monophosphate ( cAMP), initiating a cascade that lowers free intracellular calcium ions ( Ca^2+). The resulting cellular consequence is the relaxation of bronchial smooth muscle and bronchial lumen widening.

Secondarily, Theophylline functions as a non-selective antagonist at Adenosine receptors ( A1 and A2 B), blocking the release of pro-constrictive mediators and modulating peripheral respiratory signaling. A third mechanism involves the enhancement of Histone Deacetylase 2 ( HDAC2) activity, which suppresses the expression of pro-inflammatory proteins, modulating immune and inflammatory responses in the airways. Furthermore, A1 receptor antagonism in the CNS, combined with peripheral muscle effects, leads to central respiratory stimulation and enhanced diaphragm contractility, which modulate breathing mechanics.

Dosage and Administration Information

How to Use Teosona

Teosona (Choline Theophyllinate) is utilized for the long-term maintenance of airway function, and its administration is strictly guided by official prescribing information to ensure therapeutic concentration is maintained. The general use pattern is defined by the following key parameters:


Administration Scope

Category Official Administration Instruction
Route of Administration Primarily Oral for maintenance. The active agent (Theophylline) is used Intravenously (IV) in acute care settings.
Dosing Schedule Initial adult oral doses start at 300 mg to 400 mg per day, followed by titration. Maintenance doses typically range from 400 mg to 600 mg daily.
Dosing Frequency Immediate-release forms require divided doses every 4 to 8 hours. Extended-release forms are taken once daily (q24h) or twice daily (q12h).
Timing and Food The medication should be taken at consistent times each day. It may generally be taken with or without food.

Procedural and Population Requirements

Establishing the correct dose is a mandatory titration process governed by Therapeutic Drug Monitoring (TDM), where serum concentrations are measured to guide dose adjustments toward a target range of 10 to 15 mcg/mL. This concentration-guided approach is critical due to the drug’s narrow therapeutic window.

Specific rules govern certain formulations and populations. Extended-release tablets and capsules must be swallowed whole and must not be crushed, broken, or chewed to prevent the sudden release of the entire dose. Dosage calculations are based on ideal body weight. For patients over 60 years of age, the maximum daily dose is commonly restricted to 400 mg to account for potential reductions in drug clearance.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Teosona

Teosona contains Choline Theophyllinate, which is a salt form of the therapeutic agent theophylline. Research on this medication primarily involves studies of theophylline. The evidence describes the contexts and conditions for which this class of medicine was studied for use in conditions characterized by fluctuating or episodic manifestations.


Evidence for Use in Chronic Obstructive Pulmonary Disease (COPD)

Research has examined the use of this class of medicine in adults with stable COPD, focusing on those who experience chronic airflow limitation. The research landscape includes Randomized Controlled Trials (RCTs) and comprehensive meta-analyses.

Researchers primarily monitored pulmonary function tests, such as the forced expiratory volume in 1 second ( FEV1), as well as changes in exercise capacity (e.g., six-minute walk distance), to document any changes that occurred during the study period. Studies report patterns related to these physiological outcomes over short-term follow-up periods.

The body of research for short-term physiological measurements is categorized as High based on pooled data from multiple trials. However, information regarding long-term outcomes, such as sustained quality of life changes or major clinical outcomes like hospitalization, remains limited. The focus remains heavily on the parent drug, theophylline.


Evidence for Use in Bronchial Asthma

Research has explored this class of medicine in contexts related to bronchial asthma, especially in conditions involving periods of heightened symptoms. Studies often involved RCTs designed to observe patterns in lung function and symptoms in both adults and pediatric patients.

Studies report documented changes in objective measures of lung function, such as morning FEV1. Research also examined outcomes related to physical discomfort and patient-reported outcomes describing perceived discomfort, such as wheezing and shortness of breath. The research level in maintenance therapy contexts is categorized as Moderate.


Understanding the Study Landscape and Gaps

Overall, the evidence quality varies across studies, with the strength being highest for short-term physiological change. A gap in the research is the lack of comparative evidence against other treatment approaches, particularly for long-term outcomes. Furthermore, the focus on the parent drug means the specific Teosona salt form does not have as extensive a dedicated research profile as its active component. This evidence highlights what is known—and what is still uncertain—about this class of medicine.

Frequently Asked Questions (FAQ)

Common questions about Teosona (FAQ)

Q: Is it safe to drink coffee or caffeine while taking Teosona?

A: Caffeine is chemically similar to the active component of Teosona. Official drug information warns that combining them may lead to additive side effects, such as stomach upset, trouble sleeping, and an increased heart rate. A healthcare provider can be consulted about the use of caffeine, especially since dose adjustments for Teosona may be necessary.


Q: What should I do if I miss a dose of Teosona?

A: Regulatory information emphasizes taking this medication at consistent times to keep a stable amount in the body. While the importance of consistent dosing is emphasized, specific instructions for managing a missed dose are typically provided by a healthcare professional.


Q: Can I stop taking Teosona suddenly once I feel better?

A: The decision to discontinue Teosona is a determination made by a healthcare provider. Because the medication is used for long-term maintenance of chronic conditions, suddenly stopping it may be associated with the return or worsening of your underlying respiratory symptoms. Adjustments to dosage are conducted under the guidance of a healthcare professional.


Q: Is there a risk of rebound symptoms if Teosona is stopped?

A: Teosona is used to manage chronic airflow obstruction and breathing difficulties. Official documents indicate that stopping the medication may lead to a re-emergence or exacerbation of the chronic symptoms that the medicine is used to manage, as noted in the research landscape. The term 'rebound' is not specifically used in the official label.


Q: Can Teosona make me drowsy or affect my ability to drive?

A: Official labeling lists common nervous system effects like restlessness, tremors, and insomnia (trouble sleeping). Although drowsiness is not commonly cited, these Central Nervous System (CNS) effects may potentially impair an individual’s ability to perform tasks requiring high focus, such as driving.


Q: Is Teosona approved for long-term use?

A: Official regulatory documents indicate that Teosona is indicated for the treatment of chronic airway obstruction and symptoms associated with chronic lung diseases. This indication suggests suitability for long-term maintenance treatment when used under the careful direction and monitoring of a healthcare professional.


Q: Does Teosona have a 'Black Box' warning listed by the FDA?

A: Regulatory documents for the active ingredient do not typically feature a Boxed Warning (often called a 'Black Box' warning). However, there are significant Warnings and Precautions emphasized due to the drug’s narrow therapeutic range, highlighting the serious potential for toxicity, such as seizures or irregular heartbeats, if blood levels become too high.


Q: Can I crush or chew the Teosona tablets/capsules?

A: Official administration instructions state that extended-release forms of Teosona must be swallowed whole and should not be crushed, broken, or chewed. Breaking the extended-release coating could cause a sudden, rapid release of the active ingredient, which may increase the risk of toxicity.


Q: Can Teosona be used in people with diabetes or high blood sugar?

A: Regulatory information suggests that high blood sugar (hyperglycemia) is a potential sign of drug toxicity or overdose. While the presence of diabetes is not an absolute contraindication, regulatory sources indicate that individuals with pre-existing conditions may be candidates for cautious monitoring when using this class of medicine.


Q: How is Teosona different from other medicines used for the same condition?

A: Teosona is classified as a methylxanthine bronchodilator. Unlike some other respiratory medicines that primarily work by stimulating specific receptors, Teosona works through different mechanisms: by inhibiting certain enzymes (Phosphodiesterase) and by blocking the effects of adenosine in the airways to achieve muscle relaxation and improved breathing.


Q: Is it normal to feel tired when first starting Teosona?

A: While tiredness or fatigue is not explicitly listed as a common reaction, the official drug label does list central nervous system effects such as insomnia (trouble sleeping), restlessness, and irritability. Any of these common side effects could indirectly lead to feelings of tiredness or lack of energy.


Q: How long does it usually take before I can feel Teosona working?

A: The time it takes to feel the initial effects depends on the form of the medication. For immediate-release forms, the drug is quickly absorbed, and peak blood concentration, which corresponds to the maximum initial effect, is generally reached about 1 to 2 hours after taking the dose.


Q: Can Teosona affect the way other prescription drugs work?

A: Yes, Teosona is metabolized (broken down) in the liver by the enzyme CYP1A2. Other medications that either increase or decrease the activity of this enzyme can significantly change the level of Teosona in the blood, affecting its safety or effectiveness. This is why a complete list of all drugs, supplements, and products should be reviewed with a healthcare provider.


Q: Are there any foods I should definitely avoid when taking Teosona?

A: Official sources specifically caution against the consumption of large amounts of caffeine due to the risk of additive side effects. There are also warnings that a single large dose of alcohol may decrease the clearance of Teosona from the body. Otherwise, immediate-release forms are generally not associated with clinically significant changes when taken with food.


Q: What is the eligibility age to take Teosona (for children or elderly)?

A: Specific dosing guidelines exist for the use of Teosona in adolescents and children 12 years of age and older, based on body weight. However, due to variable clearance and higher risk of toxicity, special caution and dosage limits are required for older adults (over 60 years) and its use is highly restricted in infants under one year of age.


Q: Can women who are pregnant or planning pregnancy use Teosona?

A: Teosona is classified as Pregnancy Category C. Official guidance indicates that it should be used during pregnancy only if the potential benefit to the patient is considered to outweigh the potential risk to the fetus. This determination is conducted by a healthcare provider after reviewing the individual clinical context.


Q: Is Teosona safe to use while breastfeeding?

A: The active ingredient, theophylline, is known to pass into human milk. Official documents note that this may potentially cause adverse effects in a breastfed infant, such as irritability or difficulty sleeping. The risks and benefits of using the medicine while breastfeeding are evaluated by a healthcare provider.


Q: Do I need to check my blood pressure while on Teosona?

A: While routine blood pressure checks are not universally specified in labeling, low blood pressure is a documented sign of severe toxicity or overdose. However, the most critical safety measure is regular Therapeutic Drug Monitoring (TDM), which checks the concentration of the drug in your blood.


Q: Can Teosona be taken with cold or flu medicine (over-the-counter drugs)?

A: Many over-the-counter (OTC) cold and flu products contain ingredients that can interact with Teosona, such as other xanthine derivatives or sympathomimetics. These interactions can lead to increased side effects. Patients should consult a healthcare provider before taking any new medicine, including OTC cold and flu products.


Q: Does Teosona contain lactose or other common allergens?

A: The specific inactive ingredients, which include fillers and binding agents, vary by the specific product form and manufacturer. For example, some extended-release tablets are officially listed as containing anhydrous lactose. Individuals with known allergies are encouraged to check the inactive ingredient list for their prescribed product.


Q: Are the benefits of Teosona generally considered to outweigh the risks?

A: Teosona is approved and indicated for use in patients with chronic lung conditions to provide symptomatic relief and maintenance of airflow. When used appropriately with mandatory serum level monitoring to control the risks associated with its narrow therapeutic window, it is included as a recognized management option in clinical contexts.


Q: What does the research say about Teosona's use in adolescents?

A: Regulatory dosing information provides specific guidance for the use of Teosona in adolescents and children 12 to 15 years of age whose dose is calculated differently from younger children and adults. Official research evidence has also explored the use of this class of medicine in the broader pediatric patient population.


Q: Can Teosona be taken if I am due to have surgery or a medical procedure?

A: Teosona can interact with certain anesthetic agents and antibiotics commonly used during surgical procedures, potentially increasing the risk of toxicity or seizures. Regulatory documents require that healthcare teams be informed of all medications being taken prior to any medical procedure.


Q: How does the body break down (metabolize) Teosona?

A: The body primarily metabolizes theophylline, the active component, in the liver. This process is mainly carried out by a liver enzyme called CYP1A2, which converts the drug into forms that can be eliminated. Variations in this enzyme's activity are why blood monitoring is so important.


Q: How quickly does Teosona leave the system after the last dose?

A: The time required for the body to eliminate half of the drug, known as the elimination half-life, is highly variable and depends on factors like smoking status, age, and health conditions. In healthy, non-smoking adults, the average half-life is approximately 8 hours, but this can be significantly shorter or much longer in other populations.

How should Teosona be stored and disposed of?

The storage and disposal of Teosona (Oxtriphylline) must strictly follow official regulatory requirements to ensure product integrity and safety.

Required Storage Conditions

Teosona should be stored at room temperature, away from environmental factors that can cause degradation. It must be protected from excessive heat, moisture, and direct light. The medication must be kept in a tight container or with the container tightly closed to maintain chemical stability.

Safety and Disposal

It is a mandatory safety requirement to keep Teosona out of the reach of young children to prevent accidental ingestion. Any unused, expired, or unwanted portion must be disposed of safely and strictly according to local, regional, and national regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Teosona found in:

A-Z Index: